Eventide Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Eventide Asset Management’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-108,776	Closed	-$18.2M	–	175
2020 Q4	$18.2M	Sell	108,776 -50,000	-31%	-$8.89M	0.28%	94
2020 Q3	$24.8M	Hold	158,776	–	–	0.49%	65
2020 Q2	$33.2M	Hold	158,776	–	–	0.72%	50
2020 Q1	$29.6M	Buy	158,776 +50,000	+46%	+$11.8M	0.96%	39
2019 Q4	$26.3M	Hold	108,776	–	–	0.74%	52
2019 Q3	$18.4M	Buy	108,776 +31,368	+41%	+$7.1M	0.61%	59
2019 Q2	$15.1M	Hold	77,408	–	–	0.46%	69
2019 Q1	$20.5M	Hold	77,408	–	–	0.7%	54
2018 Q4	$14.9M	Hold	77,408	–	–	0.66%	53
2018 Q3	$46.4M	Hold	77,408	–	–	1.7%	18
2018 Q2	$25.6M	Buy	+77,408	New	+$27.9M	1.06%	39

Other funds holding TECX

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Eventide Asset Management's TECX Position: Q1 2021 in Review

Eventide Asset Management sold out of Tectonic Therapeutic (TECX) in Q1 2021, closing a stake of 108,776 shares — an estimated $18.2M sold.

Eventide Asset Management first reported a position in TECX in Q2 2018 and held it in 11 quarters. The position peaked at $46.4M in Q3 2018. 99 funds tracked by Wall St. Rank hold TECX as of Q1 2021.

Eventide Asset Management reported no remaining Tectonic Therapeutic position as of Q1 2021 after selling out during the quarter.
Eventide Asset Management sold 108,776 Tectonic Therapeutic shares in Q1 2021, an estimated $18.2M.
Eventide Asset Management first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 11 quarters.
Eventide Asset Management's Tectonic Therapeutic position peaked at $46.4M in Q3 2018.
99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2021.

Based on Eventide Asset Management's 13F filing for Q1 2021, filed 14 May 2021.